🇺🇸 FDA
Patent

US 9120851

Human antibodies to human angiopoietin-like protein 4

granted A61KA61K2039/505A61K31/216

Quick answer

US patent 9120851 (Human antibodies to human angiopoietin-like protein 4) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K31/216, A61K39/3955, A61K45/06